Amphastar Pharmaceuticals (NASDAQ:AMPH) is a diversified specialty pharmaceutical company focused on developing, manufacturing, and marketing generic and proprietary injectable, inhalation, and intranasal products. It also develops and manufactures products and product candidates within biologics, insulin, and vaccine markets. With a commitment to innovation and quality, Amphastar aims to enhance patient care by providing affordable and effective pharmaceutical solutions. Its projects span a variety of therapeutic areas, with an ongoing effort to expand its portfolio through robust research and development activities. The company strives to meet the evolving needs of the healthcare sector, aiming for excellence in all facets of its operation, from product development to manufacturing and compliance.